{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:33:26Z","timestamp":1780472006750,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T00:00:00Z","timestamp":1505347200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s10067-017-3822-3","type":"journal-article","created":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T15:05:50Z","timestamp":1505401550000},"page":"2455-2460","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Primary Sj\u00f6gren\u2019s syndrome: Extraglandular manifestations and hydroxychloroquine therapy"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6906-2096","authenticated-orcid":false,"given":"J.","family":"Demarchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Papasidero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Klajn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Chaparro del Moral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Rillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Martir\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Secco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Catalan Pellet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Amitrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Crow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Asnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Pucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Caeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Benzanquen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. P.","family":"Pirola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Zazzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Velez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Barreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Tamborenea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Raiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,14]]},"reference":[{"key":"3822_CR1","doi-asserted-by":"publisher","unstructured":"Ramos-Casals M, Brito-Zeron P, Siso-Almirall A, Bosch X (2012) Primary Sj\u00f6gren syndrome. BMJ 344. https:\/\/doi.org\/10.1136\/bmj.e3821","DOI":"10.1136\/bmj.e3821"},{"key":"3822_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","volume":"366","author":"RI Fox","year":"2005","unstructured":"Fox RI (2005) Sj\u00f6gren\u2019s syndrome. Lancet 366:321\u2013331. https:\/\/doi.org\/10.1016\/S0140-6736(05)66990-5","journal-title":"Lancet"},{"key":"3822_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1517\/14656566.2013.767333","volume":"14","author":"P Brito-Zer\u00f3n","year":"2013","unstructured":"Brito-Zer\u00f3n P, Sis\u00f3-Almirall A, Bov\u00e9 A, Kostov BA, Ramos-Casals M (2013) Primary Sj\u00f6gren syndrome: an update on current pharmacotherapy options and future directions. Expert Opin Pharmacother 14:279\u2013289. https:\/\/doi.org\/10.1517\/14656566.2013.767333","journal-title":"Expert Opin Pharmacother"},{"key":"3822_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/ncprheum0165","volume":"2","author":"CP Mavragani","year":"2006","unstructured":"Mavragani CP, Moutsopoulos NM, Moutsopoulos HM (2006) The management of Sj\u00f6gren\u2019s syndrome. Nat Clin Pract Rheumatol 2:252\u2013261. https:\/\/doi.org\/10.1038\/ncprheum0165","journal-title":"Nat Clin Pract Rheumatol"},{"key":"3822_CR5","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s10067-016-3175-3","volume":"35","author":"EJ Borg Ter","year":"2016","unstructured":"Ter Borg EJ, Kelder JC (2016) Polyarthritis in primary Sj\u00f6gren\u2019s syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up. Clin Rheumatol 35:649\u2013655. https:\/\/doi.org\/10.1007\/s10067-016-3175-3","journal-title":"Clin Rheumatol"},{"key":"3822_CR6","first-page":"194","volume":"96","author":"P Scagliusi","year":"2005","unstructured":"Scagliusi P, Minenna G, D\u2019Amore M, Scagliusi A (2005) New therapeutic perspectives in Sj\u00f6gren syndrome: leflunomide. Recenti Prog Med 96:194","journal-title":"Recenti Prog Med"},{"key":"3822_CR7","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1007\/s10067-016-3360-4","volume":"35","author":"C Kedor","year":"2016","unstructured":"Kedor C, Zernicke J, Hagemann A, Gamboa LM, Callhoff J, Burmester GR, Feist E (2016) A phase II investigator-initiated pilot study with low-dose cyclosporine A for the treatment of articular involvement in primary Sj\u00f6gren\u2019s syndrome. Clin Rhreumatol 35:2203\u20132210. https:\/\/doi.org\/10.1007\/s10067-016-3360-4","journal-title":"Clin Rhreumatol"},{"key":"3822_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2147\/CLEP.S47399","volume":"6","author":"R Patel","year":"2014","unstructured":"Patel R, Shahane A (2014) The epidemiology of Sj\u00f6gren\u2019s syndrome. Clin Epidemiol 6:247\u2013255. https:\/\/doi.org\/10.2147\/CLEP.S47399","journal-title":"Clin Epidemiol"},{"key":"3822_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrrheum.2012.53","volume":"8","author":"M Ramos-Casals","year":"2012","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Sis\u00f3-Almirall A, Bosch X, Tzioufas AG (2012) Topical and systemic medications for the treatment of primary Sj\u00f6gren\u2019s syndrome. Nat Rev Rheumatol 8:399\u2013411. https:\/\/doi.org\/10.1038\/nrrheum.2012.53","journal-title":"Nat Rev Rheumatol"},{"key":"3822_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.2014.7682","volume":"312","author":"JE Gottenberg","year":"2014","unstructured":"Gottenberg JE, Ravaud P, Pu\u00e9chal X, Le Guern V et al (2014) Effects of hydroxychloroquine on symptomatic improvement in primary Sj\u00f6gren syndrome: the JOQUER randomized clinical trial. JAMA 312:249\u2013258. https:\/\/doi.org\/10.1001\/jama.2014.7682","journal-title":"JAMA"},{"key":"3822_CR11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL et al (2002) Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554\u2013558","journal-title":"Ann Rheum Dis"},{"key":"3822_CR12","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1056\/NEJM199101173240303","volume":"324","author":"The Canadian Hydroxychloroquine Study Group","year":"1991","unstructured":"The Canadian Hydroxychloroquine Study Group (1991) A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J Med 324:150\u2013154","journal-title":"N Engl J Med"},{"key":"3822_CR13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0889-857X(21)00233-7","volume":"20","author":"D Wallace","year":"1994","unstructured":"Wallace D (1994) Antimalarial agents and lupus. Rheum Dis Clin N Am 20:243\u2013263","journal-title":"Rheum Dis Clin N Am"},{"key":"3822_CR14","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/art.23449","volume":"58","author":"SA Saunders","year":"2008","unstructured":"Saunders SA, Capell HA, Stirling A, Vallance R, Kincaid W, McMahon AD, Porter DR (2008) Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies. Arthritis Rheum 58:1310\u20131317","journal-title":"Arthritis Rheum"},{"key":"3822_CR15","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1177\/0961203312437270","volume":"21","author":"R Willis","year":"2012","unstructured":"Willis R, Seif AM, McGwin G Jr, Martinez-Martinez LA, Gonz\u00e1lez EB, Dang N, Papalardo E, Liu J, Vil\u00e1 LM, Reveille JD, Alarc\u00f3n GS, Pierangeli SS (2012) Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort. Lupus 21:830\u2013835. https:\/\/doi.org\/10.1177\/0961203312437270","journal-title":"Lupus"},{"key":"3822_CR16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/ard.52.5.360","volume":"52","author":"AA Kruize","year":"1993","unstructured":"Kruize AA, Hen\u00e9 RJ, Kallenberg CG, van Bijsterveld OP, van der Heide A, Kater L, Bijlsma JW (1993) Hydroxychloroquine treatment for primary Sj\u00f6gren\u2019s syndrome: a two year double blind crossover trial. Ann Rheum Dis 52:360\u2013364","journal-title":"Ann Rheum Dis"},{"key":"3822_CR17","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3346\/jkms.2016.31.7.1127","volume":"31","author":"CH Yoon","year":"2016","unstructured":"Yoon CH, Lee HJ, Lee EY, Lee EB, Lee WW, Kim MK, Wee WR (2016) Effect of hydroxychloroquine treatment on dry eyes in subjects with primary Sj\u00f6gren\u2019s syndrome: a double-blind randomized control study. J Korean Med Sci 31:1127\u20131135. https:\/\/doi.org\/10.3346\/jkms.2016.31.7.1127","journal-title":"J Korean Med Sci"},{"key":"3822_CR18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0002-9343(88)90365-8","volume":"85","author":"RI Fox","year":"1988","unstructured":"Fox RI, Chan E, Benton L, Fong S, Friedlaender M, Howell FV (1988) Treatment of primary Sj\u00f6gren\u2019s syndrome with hydroxychloroquine. Am J Med 85:62\u201367","journal-title":"Am J Med"},{"issue":"Suppl 1","key":"3822_CR19","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1177\/096120339600500108","volume":"5","author":"R Fox","year":"1996","unstructured":"Fox R, Dixon R, Guarrasi V, Krubel S (1996) Treatment of primary Sj\u00f6gren\u2019s syndrome with hydroxychloroquine: a retrospective, open-label study. Lupus 5(Suppl 1):S31\u2013S36","journal-title":"Lupus"},{"key":"3822_CR20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard.58.4.253","volume":"58","author":"M Tishler","year":"1999","unstructured":"Tishler M, Yaron I, Shirazi I, Yaron M (1999) Hydroxychloroquine treatment for primary Sj\u00f6gren\u2019s syndrome: its effect on salivary and serum inflammatory markers. Ann Rheum Dis 58:253\u2013256","journal-title":"Ann Rheum Dis"},{"key":"3822_CR21","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s00296-010-1415-4","volume":"31","author":"S Yavuz","year":"2011","unstructured":"Yavuz S, Asfuro\u011flu E, Bicakcigil M, Toker E (2011) Hydroxychloroquine improves dry eye symptoms of patients with primary Sj\u00f6gren\u2019s syndrome. Rheumatol Int 31:1045\u20131049. https:\/\/doi.org\/10.1007\/s00296-010-1415-4","journal-title":"Rheumatol Int"},{"key":"3822_CR22","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12891-017-1543-z","volume":"18","author":"SQ Wang","year":"2017","unstructured":"Wang SQ, Zhang LW, Wei P, Hua H (2017) Is hydroxychloroquine effective in treating primary Sjogren\u2019s syndrome: a systematic review and meta-analysis. BMC Musculoskeletal Disord 18:186. https:\/\/doi.org\/10.1186\/s12891-017-1543-z","journal-title":"BMC Musculoskeletal Disord"},{"key":"3822_CR23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.reuma.2010.01.004","volume":"6","author":"F Zazzetti","year":"2010","unstructured":"Zazzetti F, Rivero M, Duartes Noe DE, Gallacher A, Schiel A, Khoury MC, Laborde HA, Barreira JC (2010) Frequency of systemic manifestations in patients with primary Sjogren\u2019s syndrome in Argentina. Reumatol Clin 6:299\u2013302. https:\/\/doi.org\/10.1016\/j.reuma.2010.01.004","journal-title":"Reumatol Clin"},{"key":"3822_CR24","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/rheumatology\/ket349","volume":"53","author":"M Ramos-Casals","year":"2014","unstructured":"Ramos-Casals M, Brito-Zeron P, Solans R, Camps MT, Casanovas A et al (2014) Systemic involvement in primary Sj\u00f6gren\u2019s syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients. Rheumatology (Oxford) 53:321\u2013331. https:\/\/doi.org\/10.1093\/rheumatology\/ket349","journal-title":"Rheumatology (Oxford)"},{"key":"3822_CR25","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1093\/rheumatology\/kev200","volume":"54","author":"M Ramos-Casals","year":"2015","unstructured":"Ramos-Casals M, Brito-Zeron P, Seror R, Bootsma H, Bowman S et al (2015) Characterization of systemic disease in primary Sj\u00f6gren\u2019s syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology (Oxford) 54:2230\u20132238. https:\/\/doi.org\/10.1093\/rheumatology\/kev200","journal-title":"Rheumatology (Oxford)"},{"key":"3822_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1586\/1744666X.2016.1109449","volume":"12","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n P, Theander E, Baldini C, Seror R, Retamozo S et al (2016) Early diagnosis of primary Sj\u00f6gren\u2019s syndrome: EULAR-SS task force clinical recommendations. Expert Rev Clin Immunol 12:137\u2013156. https:\/\/doi.org\/10.1586\/1744666X.2016.1109449","journal-title":"Expert Rev Clin Immunol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-017-3822-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3822-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-017-3822-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T21:21:21Z","timestamp":1659475281000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-017-3822-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,14]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["3822"],"URL":"https:\/\/doi.org\/10.1007\/s10067-017-3822-3","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,14]]}}}